1. Home
  2. BDRX

as of 01-15-2026 1:10pm EST

$2.18
+$0.09
+4.31%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Founded: 2000 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 4.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 981.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -53.50 EPS Growth: N/A
52 Week Low/High: $2.06 - $92.00 Next Earning Date: 09-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered BDRX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 21 hours ago

AI Recommendation

hold
Model Accuracy: 0.00%
0.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: